Based on these findings, TN-ET cases were stratified into two groups (CREB3L1-positive TN-ET and CREB3L1-negative TN-ET) and the clinical parameters of the two groups were monitored. This evidence concerns the gene CREB3L1 and essential thrombocythemia.